Dynamic Industri (524818)

Score breakdown: P/E: 2/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at a 46% discount to book value: ₹72.02 price vs ₹156.72 book value, providing a potential margin of safety.
• Low P/E of 15.49 on a very small earnings base; if operations stabilise, even modest profit recovery can move the stock sharply.
• Rough price-to-sales of about 0.4x using the latest quarter's ₹14 Cr annualised, showing very low market expectations.
• Dividend yield of 1.05% offers a small but real income cushion while waiting for a turnaround.
• Book value per share of ₹156.72 gives a tangible asset backing far above the current market price.

Concerns

• Latest quarter net profit is ₹0 Cr on ₹14 Cr sales, meaning there is no current earning power to justify reliance on the asset discount.
• Piotroski F-score of 3/9 indicates weak financial health and possible deterioration in operating efficiency or balance-sheet quality.
• ROE of 3.94% and ROCE of 5.68% are far below acceptable returns on capital; the assets themselves are earning very little.
• Sales are declining at -2.35% and the price is below the 52-week low of ₹83.20, signalling negative momentum and possible deterioration.

AI Analysis

As I sit with this business, I am reminded that price is what you pay, value is what you get. Dynamic Industri is a small specialty chemicals company with a market cap of just ₹22 Cr, trading at ₹72.02 against a book value of ₹156.72 — a P/B of 0.46. On the surface, that looks like deep value, the kind of equation Graham would study carefully. But value investing is not buying cheap numbers; it is buying dependable earning power at a discount. Here the earning power is feeble. ROE is only 3.94%, ROCE is 5.68%, sales have shrunk by 2.35%, and profit growth is flat at 0.00%. The latest quarter tells a starker story: ₹14 Cr of sales produced roughly ₹0 Cr of net profit. A Piotroski F-score of 3/9 adds to my caution. This is not a business generating cash; it is a collection of assets earning modest returns. I do not see a moat. Specialty chemicals can be a decent niche, but at this scale—₹22 Cr market cap—there is rarely pricing power, and falling sales suggest competition or weak demand. A 1.05% dividend will not compensate me while I wait. The stock is also trading below its 52-week low of ₹83.20, which tells me the market is marking it down for a reason. The asset-play angle is real: at 46% of book value, there is theoretically a margin of safety. But book value only matters if the assets are worth that number on a going-concern or liquidation basis, and with zero current net profit I cannot simply assume that. I need to see what those assets consist of and whether debt or inefficiency is eating into value. If management can stabilise operations and earn even a modest return on that book, the upside is large. Until then, this is a possible asset play, not a proven investment. In Graham's words, it is a bargain only if the numbers and the balance sheet hold up under scrutiny.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer